Vireo Growth (VREOF) Non Operating Income (2020 - 2026)

Vireo Growth (VREOF) reported Non Operating Income of -$13.2 million for Q1 2026, down 230.0% on a YoY basis from $10.2 million in Q1 2025, and down 203.72% sequentially from $12.7 million in Q4 2025.

Vireo Growth (VREOF) Non Operating Income (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Non Operating Income data on file, last reported at -$13.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 230.0% year-over-year to -$13.2 million; the trailing twelve-month figure through Mar 2026 stood at -$22.3 million (up 17.21% YoY), and the FY2025 full-year result was -$15.9 million, up 47.78% from the prior year.
  • Non Operating Income retreated to -$13.2 million in Q1 2026, from $12.7 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $12.7 million in Q4 2025 to a low of -$13.8 million in Q3 2025.
  • A 5-year average of -$6.8 million and a median of -$7.6 million in 2022 frame the typical range for Non Operating Income.
  • Across the five-year window, Non Operating Income slumped 1505.39% in 2022 and surged 221.01% in 2025, its largest moves.
  • Tracing VREOF's Non Operating Income over 5 years: stood at -$8.0 million in 2022, then retreated by 11.68% to -$9.0 million in 2023, then retreated by 17.16% to -$10.5 million in 2024, then surged by 221.01% to $12.7 million in 2025, then sank by 203.72% to -$13.2 million in 2026.
  • Business Quant data shows VREOF's Non Operating Income at -$13.2 million in Q1 2026, $12.7 million in Q4 2025, and -$13.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -7.50 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn -13.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.20 Mn
Dec 31, 2025 12.73 Mn
Sep 30, 2025 -13.76 Mn
Jun 30, 2025 -8.06 Mn
Mar 31, 2025 -4.00 Mn
Dec 31, 2024 -10.52 Mn
Sep 30, 2024 -6.39 Mn
Jun 30, 2024 -6.02 Mn
Mar 31, 2024 -7.53 Mn
Dec 31, 2023 -8.98 Mn
Sep 30, 2023 -7.62 Mn
Jun 30, 2023 -4.69 Mn
Mar 31, 2023 -7.11 Mn
Dec 31, 2022 -8.04 Mn
Sep 30, 2022 -7.59 Mn
Jun 30, 2022 -5.45 Mn
Mar 31, 2022 -8.55 Mn
Dec 31, 2021 -3.52 Mn
Sep 30, 2021 -2.18 Mn
Jun 30, 2021 -2.85 Mn